- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2015
- Public Summary Document (PSD) July 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2015 PBAC Meeting - Word
Afatinib dimaleate – July 2015
Afatinib dimaleate; 20 mg tablet, 28; 30 mg tablet, 28; 40 mg tablet, 28; 50 mg tablet, 28; Giotrif®
Last updated
1 November 2015